Role of digital biomarkers in neurodegenerative diseases

Abstract

The advent of digital biomarkers has revolutionized the diagnostic and management landscape of neurodegenerative diseases, offering unprecedented insights into the physiological and behavioral changes associated with Multiple Sclerosis (MS), Alzheimer‘s Disease (AD), and Parkinson‘s Disease. Digital biomarkers, defined as objective and quantifiable data obtained from digital devices, include crucial metrics such as gait speed and movement analysis. In this research how digital biomarkers can reveal vital information regarding disease progression is demonstrated, and the integration of technology into clinical practice as a means to enhance patient care is highlighted. By examining the role of digital biomarkers in the context of neurodegenerative diseases, the potential for improving diagnostic accuracy and treatment outcomes is underscored in this work, ultimately leading to a better quality of life for affected individuals.